title: [Monitoring of antiplatelet drug effects--fashion or necessity?].
authors.affiliation: III Katedra i Oddział Kliniczny Kardiologii, Slaskie Centrum Chorób Serca, ul. Szpitalna 2, 41-800 Zabrze. wiktor6@wp.pl
authors.forename: Wiktor
authors.initials: W
authors.lastname: Kuliczkowski
authors.forename: Marian
authors.initials: M
authors.lastname: Zembala
authors.forename: Lech
authors.initials: L
authors.lastname: Poloński
authors.forename: Jacek
authors.initials: J
authors.lastname: Kaczmarski
authors.forename: Mariusz
authors.initials: M
authors.lastname: Gasior
mesh_terms: D000074:Acenocoumarol / Q000494:pharmacology / Q000627:therapeutic use; D001241:Aspirin / Q000494:pharmacology / Q000627:therapeutic use; D001792:Blood Platelets / Q000187:drug effects*; D000077144:Clopidogrel; D016903:Drug Monitoring; D006493:Heparin / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D019934:International Normalized Ratio; D010314:Partial Thromboplastin Time; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use*; D010979:Platelet Function Tests; D011517:Prothrombin Time; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use
chemical_list: D010975:Platelet Aggregation Inhibitors; D006493:Heparin; D000077144:Clopidogrel; D000074:Acenocoumarol; D013988:Ticlopidine; D001241:Aspirin